Press Release From Corporate Social Responsibility To Global Consensus: Chery's "Ride Green Life" Unites the World for a Sustainable Future WUHU, China, Oct. 20, 2025 /PRNewswire/ — As the global automotive industry… CISION PRNewswireOctober 20, 2025
Press Release Agoda Spotlights Unique Asian Airports Redefining the Layover Experience SINGAPORE, Oct. 20, 2025 /PRNewswire/ — Digital travel platform Agoda has unveiled… CISION PRNewswireOctober 20, 2025
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions LONDON, Oct. 20, 2025 /PRNewswire/ — Accord Plasma B.V., a subsidiary of Intas… CISION PRNewswireOctober 20, 2025
Press Release Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO CHENGDU, China, Oct. 20, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the… CISION PRNewswireOctober 20, 2025
Press Release MILESEEY GenePro G1 Named to TIME's "The Best Inventions of 2025: Special Mentions" The first "GPS + Laser" hybrid rangefinder redefining how golfers see and… CISION PRNewswireOctober 20, 2025
Press Release Chengdu CATANIA's Tower 2 Debuts Globally: A 222-Meter-High Sky Residence Redefining Global Luxury Living. CHENGDU, China, Oct. 20, 2025 /PRNewswire/ — A news report from CNS:… CISION PRNewswireOctober 20, 2025
Biparatopic HER2-targeting ADC JSKN003 Was Granted Another Breakthrough Therapy Designation for HER2-Positive Advanced Colorectal Cancer SUZHOU, China, Oct. 20, 2025 /PRNewswire/ — October 20, 2025- Alphamab Oncology (stock… CISION PRNewswireOctober 20, 2025
Alphamab Oncology Presented Multiple Clinical Data on Biparatopic HER2-targeting ADC JSKN003 at ESMO Congress 2025 SUZHOU, China, Oct. 20, 2025 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK)… CISION PRNewswireOctober 20, 2025
